Page last updated: 2024-08-25

nipradilol and glutamic acid

nipradilol has been researched along with glutamic acid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akaike, A; Katsuki, H; Kume, T; Shirakawa, H; Taguchi, R; Yamaguchi, T1
Agarwal, N; Kanamori, A; Nagai-Kusuhara, A; Nakamura, M; Nakanishi, Y; Negi, A; Tatsumi, Y1

Other Studies

2 other study(ies) available for nipradilol and glutamic acid

ArticleYear
Nitric oxide-mediated effect of nipradilol, an alpha- and beta-adrenergic blocker, on glutamate neurotoxicity in rat cortical cultures.
    European journal of pharmacology, 2006, Mar-27, Volume: 535, Issue:1-3

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Calcium; Cell Survival; Cells, Cultured; Cerebral Cortex; Cyclic GMP; Dizocilpine Maleate; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Fetus; Glutamic Acid; Glutathione; Lactoylglutathione Lyase; Neurons; Neuroprotective Agents; Nitric Oxide; Pregnancy; Propanolamines; Rats; Rats, Wistar

2006
Nipradilol protects rat retinal ganglion cells from apoptosis induced by serum deprivation in vitro and by diabetes in vivo.
    Current eye research, 2008, Volume: 33, Issue:8

    Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Apoptosis; Calcium; Caspase 3; Cell Line; Cell Survival; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP-Dependent Protein Kinases; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dose-Response Relationship, Drug; Glutamic Acid; In Situ Nick-End Labeling; Male; Propanolamines; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells; Serum; Vasodilator Agents

2008